Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 999 999.9999 KRW Market Closed
Market Cap: 45.1T KRW

Intrinsic Value

The intrinsic value of one Samsung Biologics Co Ltd stock under the Base Case scenario is 1 008 385.3656 KRW. Compared to the current market price of 999 999.9999 KRW, Samsung Biologics Co Ltd is Undervalued by 1%.

Intrinsic Value
1 008 385.3656 KRW
Undervaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Samsung Biologics Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Samsung Biologics Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Samsung Biologics Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Samsung Biologics Co Ltd.

Explain Valuation
Compare Samsung Biologics Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Samsung Biologics Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Samsung Biologics Co Ltd

Current Assets 6.4T
Cash & Short-Term Investments 1.9T
Receivables 1.2T
Other Current Assets 3.3T
Non-Current Assets 12T
Long-Term Investments 60.8B
PP&E 6.2T
Intangibles 5.4T
Other Non-Current Assets 336.4B
Current Liabilities 3.8T
Accounts Payable 296.9B
Accrued Liabilities 644.8B
Short-Term Debt 152B
Other Current Liabilities 2.7T
Non-Current Liabilities 2.4T
Long-Term Debt 896.1B
Other Non-Current Liabilities 1.5T
Efficiency

Free Cash Flow Analysis
Samsung Biologics Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Samsung Biologics Co Ltd

Revenue
5.5T KRW
Cost of Revenue
-2.4T KRW
Gross Profit
3.1T KRW
Operating Expenses
-1.1T KRW
Operating Income
2T KRW
Other Expenses
-420.9B KRW
Net Income
1.6T KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Samsung Biologics Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Exceptional Operating Margin
Exceptional Gross Margin
Strong 3Y Average Operating Margin
Healthy Net Margin
58/100
Profitability
Score

Samsung Biologics Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Samsung Biologics Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
87/100
Solvency
Score

Samsung Biologics Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Samsung Biologics Co Ltd

Wall Street analysts forecast Samsung Biologics Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Samsung Biologics Co Ltd is 2 328 600.7195 KRW with a low forecast of 1 233 210 KRW and a high forecast of 4 036 032.0657 KRW.

Lowest
Price Target
1 233 210 KRW
23% Upside
Average
Price Target
2 328 600.7195 KRW
133% Upside
Highest
Price Target
4 036 032.0657 KRW
304% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Samsung Biologics Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Samsung Biologics Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Samsung Biologics Co Ltd stock?

The intrinsic value of one Samsung Biologics Co Ltd stock under the Base Case scenario is 1 008 385.3656 KRW.

Is Samsung Biologics Co Ltd stock undervalued or overvalued?

Compared to the current market price of 999 999.9999 KRW, Samsung Biologics Co Ltd is Undervalued by 1%.

Back to Top